A traditional Chinese medicine active ingredient composition with the effect of raising white blood cells
A technology for increasing leukocytes and active ingredients, applied in the field of traditional Chinese medicine active ingredient compositions for treating leukopenia, can solve the problems of increasing leukocytes, expensive side effects of new drugs, inaccurate treatment effects, etc. Good promotion value and remarkable curative effect
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Publication Date
- 2022-01-28
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of traditional Chinese medicine preparations, and in particular relates to a traditional Chinese medicine active ingredient composition with the effect of increasing white blood cells, which is used for treating leukopenia. Background technique
[0002] Leukopenia refers to the continuous white blood cell count in peripheral blood <4.0×10 9 / L, is a common blood disease, often manifested as weakness, palpitations, dizziness, limp limbs, insomnia and dreaminess. When white blood cell count < 2.0×10 9 / L, the absolute value of neutrophils <0.5×10 9 / L, manifested as sudden headache, joint pain, extreme fatigue, etc., severe cases even have symptoms such as dysphagia, and the mortality rate is extremely high.
[0003] The main therapeutic chemical drugs for leukopenia include traditional drugs lithium carbonate and vitamin B4, and new drug colony-stimulating factors. However, the therapeutic effect...
Examples
Embodiment Construction
[0012] In order to make the objects and advantages of the present invention clearer, the present invention will be further described in detail below in conjunction with the examples. The specific embodiments described here are only used to explain the present invention, not to limit the present invention.
[0013] ICR mice were weighed, numbered, and randomly divided into blank control group, model group, single-component experimental group, group combination experimental group and positive drug Lvjiao Buxue Granules group (LJG). On the 1st day of the experiment, the model was established. The mice in the model group were intraperitoneally injected with cyclophosphamide 80 mg / kg to establish the leukopenia model. The mice in the normal group were given an equal volume of sterilized water for injection for 3 consecutive days. The single-component experimental group, the combination experimental group and the LJG group were given corresponding drugs for 7 days on the basis of th...